RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.

Add to Collection
2016 Nov Others Fist_Author_Year_PM

Full Author : ['Agrawal, Sweety', 'Gupta, Yashdeep']
Journal Title : Diabetes care
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

.....

Keywords : ["kazda et al evaluation", "phase study diabetes care", "glucagon receptor antagonist", "type diabetes", "safety", "patient", "efficacy", "comment"]